Therapeutic potency of compound RMY-205 for pulmonary fibrosis induced by SARS-CoV-2 nucleocapsid protein-Reference-Cited by-同舟云学术

Therapeutic potency of compound RMY-205 for pulmonary fibrosis induced by SARS-CoV-2 nucleocapsid protein

Published:2023-03 Issue:3 Volume:30 Page:261-277.e8
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Zhang Zhi-yuan,Ju Cui-yu,Wu Liu-zheng,Yan Han,Hong Wen-bin,Chen Hang-zi,Yang Peng-bo,Wang Bao-Rui,Gou Tong,Chen Xiao-yan,Jiang Zhi-hong,Wang Wei-jia,Lin Tianwei,Li Fu-nan,Wu Qiao

Funder

Xiamen University

National Natural Science Foundation of China

Natural Science Foundation of Fujian Province

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference49 articles.

1. SARS-CoV-2 pathogenesis;Lamers;Nat. Rev. Microbiol.,2022

2. A novel coronavirus outbreak of global health concern;Wang;Lancet,2020

3. Post-acute COVID-19 syndrome;Nalbandian;Nat. Med.,2021

4. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy;George;Lancet Respir. Med.,2020

5. COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts;John;Immunol. Rev.,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytoconstituents as modulator of inflammatory pathways for COVID‐19: A comprehensive review and recommendations;Phytotherapy Research;2024-09-09

2. An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivo;Virologica Sinica;2024-06

3. The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view;Biomedicines;2024-03-13